Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Surgibot was incapable of achieving FDA approval. Might as well have been a used car. Very little IP associated with it.
Message in reply to:
FDA rejected Surgibot was sold for $29m.
Thanks, hearyou!
Unfortunately now I go to a 9:30 meeting which will probably suck up most of my morning and half of my spirituality! But I hope to see some good replies and contributions by lunchtime.
Gets ugly??? Hello... McFly!!! We have arrived at ugly.
On the other hand, fire sale at $100M is out of the question. The tech in the patents alone is worth many many times that. The only real execution risk right now is with funding. As per usual in Titanland, where the bus full of ugly is unloading today.
Message in reply to:
Titan better have monster Q4 execution or this thing gets ugly real fast. Fire sale for $100m-$200m is not out of the question. Big guns are waiting on the side lines to gobble it up. Execution risk is real and staring us longs in the face.
Gosh, I'm honored that you chose my post to reply to in your comeback...
But I can't tell if you are agreeing with me ("McNally should replace him") or disagreeing by blaming Mr. McNally for the CFO's continued existence with the organization.
Message in reply to:
MACNALLY IS THE CEO! The buck stops with him....if the CFO can’t get it done MACNALLY should replace him!!!
I’m back baby!!!!
I don't think Mr. McNally is the right guy for this job. BECAUSE IT'S THE CFO'S JOB!!! This is a FINANCIAL issue. Maybe the CHIEF FINANCIAL OFFICER should step up to the plate here.
At least you should point your hate in the right direction; this isn't pure politics here...
Mr. McNally is bringing us a world class medical device, ISO 13485 certification, and a market-ready solution for real world problems (like how can a small hospital afford da Vinci).
My only real questions for him now are:
1. when will he realize that his Rock is turning him into Sisyphus?
2. What the ph*q is an enos?
On a day like today, which hopefully is a one-of-a-kind day, my only gripe with Mr. McNally is that he hasn't brought in a new CFO.
Message in reply to:
If 1.33 doesn't hold - it is going to get UGLY UGLY. I hope it doesn't folks - but you better have a mask at the ready.
I dunno - Is Mc the right guy for this ? Fair question
You say that like it's a bad thing! How about...
"Probably submitting in 30 to 45 days, with approval no more than a month after that!"
Beats the hell out of Medtronic's two year timeline!
Message in reply to:
...And that isn't going to be submitted in 6 or 7 days. Probably more like 30-45 days away and then up to a month after that for approval.
The IDE approval is really a big deal; it means the FDA is sufficiently satisfied with the safety and efficacy of the device enough to allow live human trials. Titan has been working with the FDA for YEARS now to ensure they will meet all necessary criteria when we file for the IDE.
The only thing I'm missing right now is a statement from management indicating the status or completion of the design tweaks, which surely are needed in advance of the filing - they can't tell the FDA "We want to use something like this but different..."
So once the IDE application is in, the design is locked down, and we are truly ROLLING! I only hope our share price will reflect that fact...
Message in reply to:
Thanks broheim steamroller. Im not fretting, IDE submttal in Q4 is huge and if we can pull it off it will be the beginning of the beginning! Big times ahead in titanville. After all these years, things are finally materializing. Long focus on the big picture shows things are looking up.
Maybe the reception for MDTs system will be poor enough to make them reconsider... They could just plunk down a few Billy and have a state-of-the-art single port solution ready to go in less than half the time it will take to get their thing(s) to market. Or they can proceed on their merry way as planned, emulating Transenterix...
Hey, did Trixie also have a processing tower separate from the surgeon's console? Or were they integrated into one unit? Just wondering if Senhance was actually more efficient in the cart count.
Can't scoop 'em today! The candy store seems to be closed!
Message in reply to:
Scooooooooooop em
After seeing the pictures on line of MDT's new system, I can't help but think it is a slightly smaller version of Trixie's system, but with an extra cart to move around. I suppose I need not comment on how well Senhance was received in the general marketplace.
In my opinion, it substantially validates Titan's inherent value, and possibly also lends further credence to the notion that our IP program for single port is pretty solid and hence substantially valuable.
Maybe our continued trading halt is based on the MDT unveiling this afternoon, knowing that once folks see Senhance 2.0, they will think Titan is worth hanging onto. Could be we are letting MDT support our share price for the raise!
All just my opinion, of course...
To your "not even close" point... It would be very entertaining if Medtronic shows off a single port offering which is:
-Obviously inferior to SPORT/ENOS or ISRG SP
-Unwieldy in size in the limited-space OR environment
-Absurdly expensive
-Blatantly ripping off Titan or ISRG patents
I doubt they would tread on ISRG patents. ISRG has the money to fight it and win. Titan not only doesn't have the money, they don't have sales yet, so there would be no immediate financial losses, and therefore little basis for an infringement lawsuit until we get to the market. However...
When da Vinci first came to the marketplace, Computer Motion had some IP (for their Zeus system) which ISRG was clearly treading upon, so they sued ISRG... and before the case was settled, ISRG bought Computer Motion (legally, they merged...) and Computer Motion was granted 32% ownership of ISRG - 32% of ISRG is near $20B today with appreciation of ISRG stock!
So given how little IP Medtronic appears to have for single port, and the vast unlikelihood that they would want a legal battle with ISRG, there is a reasonable possibility that they could tread on some Titan IP and be forced to do something similar a couple years in the future. So for two more years of this prolonged agony of Titan stock ownership, the rewards could conceivably be beyond our wildest dreams!
Okay, daydream over... back to work for me!
Message in reply to:
suckitup Thursday, 09/19/19 06:47:38 PM
Re: None
Post #96351 of 96372
I FOR ONE WILL MISS SPORT'S 60 POSTS A DAY...NOT!!!!!!!!!!!!!!!!!!!! I DO NOT BELIEVE MEDTRONIC IS INVOLVED AT ALL WITH TITAN...THEY DO NOT EVEN SNIFF AROUND IF NOT FDA APPROVED.....I ALSO THINK THE PPS WILL REMAIN STABLE UNTIL THERE IS SIGNIFICANT NEWS.... TUESDAY WILL COME AND GO...MEDTRONIC WILL SHOW THE CARDS...NOT EVEN CLOSE TO WHAT TITAN HAS TO OFFER...AND THE SAGA WILL CONTINUE....
Unfortunately, I can't say that I am sorry to hear that, but mostly because this has not been a happy place for you for a long time. Despite our frequently contentious exchanges, I still wish you the best moving forward. Your early contributions were often insightful and when you shared real due diligence, it was truly appreciated.
Go be happy and be well.
Message in reply to:
You’ll be happy to know this will be my last post on the TMDI board. Since I don’t post anywhere else this is the last you’ll hear from me on Titan Medical. I’ll be giving up my moderator position as well.
Horrible investment.
Moving on.
Bro, I was using numbers from Honeycomb's source he posted a couple days ago:
https://marketwirenews.com/stock/tmdi/short/
He actually posted two different sources but the daily volume on the other page didn't seem to match what every other source showed, so I went with the one above.
I am using their reported daily trade volume and daily short volume to determine percentage of shares traded short that day.
HC also just recently posted something about a million-ish shares short at the moment. Given a reported outstanding count around 32M, your report of 3.45% seems to match his report of a million-ish short shares at the moment.
Message in reply to:
Question for you. When you say short interest, you're talking about daily trade volume or overall outstanding shares? I see total overall short interest as only 3.45%. It looks to me like short interest isn't really expanding, just that those shares are more active lately.
I used Market Watch for short interest info.
https://www.marketwatch.com/investing/stock/tmdi
Maybe I am onto something, but it was someone else's theory in the Tree Fort. I was just looking to substantiate it further. So far the theory is holding up!
Message in reply to:
Maybe Mustang's on to something
Yesterday short percentage was 29%, up from 22% on Tuesday... I expected that increase. I suspect you just might see a second consecutive day of increase today, given our anemic volume so far, unless some late breaking news boosts our volume substantially.
HC, I will grant you this... in terms of short shares, not percent short but actual number of shares, this week is far outpacing the last two. For the first three days of this week, the average short share count is almost 111K shares. Last week's average was half that, at just under 55K. And the week before (the holiday week but these are daily averages for the week) was only 33K shares.
To sum the weekly AVERAGES to date for the past 3 weeks:
Week of Sep 3-6:
150K shares traded, 33K shorted, 22% short.
Week of Sep 9-13:
208K shares traded, 55K shorted, 26% short.
Week of Sep 16-18 (so far this week):
392K shares traded, 11K shorted, 28% short.
So yes, to the extend we could possibly consider this a trend based on weekly averages, short shares are increasing a lot, and short percentage is increasing a little, but overall daily volume is jumping up substantially as well, with this week's average daily volume being about 3.3TIMES as much as the week before last, and nearly double last week's average daily volume.
Today's weak overall volume will probably drop some of these average numbers for this week thereby making it easier for the short percentage to increase.
Average volume up this month may indicate more eyes on Titan, maybe indicative of some level of success at these recent conferences. And short volume up may indicate... anything, really. Could mean shorters remain confident in this providing them a comfortable living for some time to come. Or it could mean
they view this as their last hurrah; with only a couple days left to try to manipulate this PPS they are going all in, and bailing out on Tuesday/Wednesday next week.
At least with average daily volume generally increasing, it means there is a likelihood of more support overall, and a better chance of staying over the $2.00 line until some sort of news moves us substantially one way or the other!
All of this just my two cents (and maybe not worth that much!)...
Message in reply to:
Mexican standoff - who blinks first ? Hard to argue the FACTS...short volume as been increasing. More folks taking a short position in August vs July. Sept. data can easily be seen on Fintel as well.
It's all there. No new eyes coming until 9/24. Rest of today and tomorrow and perhaps 1/2 day on Monday. GLTA
Great video! I still wish they deployed the camera wash system (in their IP portfolio) but maybe they are keeping it for ENOS 2.0 or will sell it as a future upgrade.
Yesterday I had asked if anyone has heard from management in the past few weeks... no replies. Maybe it was the wrong question. So...
Has anyone reached out to management in the past few weeks expecting a reply, but never received a reply? Just trying to gauge if they have gone into blackout mode, maybe pending some huge news or a contractual obligation placed on them by an acquirer of some sort.
Message in reply to:
Look at this video compared to fish in a chicken bowl and tell me McNally isn’t the real deal ! https://titanmedicalinc.com/technology/
HC, I'm going to try to fix your typo...
Where you referenced "the $6.50 buyout" I think you must have meant "the $6.5B buyout" instead. It should be a "B" where you typed a "0".
Message in reply to:
Eddie - people need to buy all they can at $1 and then hold until the $6.50 buyout in early 2021. It's as simple as that (sigh)
Nobody asked me, but...
I don't know if I would want to settle for that little. To me, the IP alone is worth at least $1.5B to $2B. If single port wasn't the future of robotic surgery, ISRG wouldn't have entered (created!) that market. And with the combined patent list of Titan and ISRG for single port, it will be very difficult for yet another competitor to step in without stepping on existing patents. Add our snake arm advantage, smaller footprint, lower price, single-use end effectors, etc. etc. - the value is clearly high.
An all stock deal means the PFIC rules go away for those of us who knew nothing about it when we bought in, so I'm for that! But I would like to see at least $2B to $2.5B this month... and the closer we get, the higher it should go. IDE approval? Let's start at $3B! 510K approval? $4.5B on up; sky's the limit as more indications are added!
And on the phone, I call him David. After all, that is his name.
Message in reply to:
If it were an all stock acquisition by ISRG, then I would take $1B-$1.5B today. With that being said, my risk tolerance and time horizon prefers TMDI to go it alone through at least the first year of commercialization, in order to maximize my ROI over what will be a nearly decade long investment (although the bulk of my investment here has been since David took over as CEO).
Just to bring closure to a recent topic...
Yesterday 573K shares traded, and 128K of those were short sales.
Quick division shows that would be 22.3% short. The previous day showed 41.6% short. So back to more basic math:
41.6 - 22.3 = -19.3%. The increase in short percentage yesterday was NEGATIVE 19.3%. I think that actually implies a decrease, not an increase. But I'm not calling it a "trend" after just one day.
If I had to bet (although it's not something I would really bet on because it is fairly random) I would guess that the short percentage will increase today. If for some reason it does not, it COULD indicate that the shorters are getting a little spooked, as they rightfully should be. Someone did some really nice scooping yesterday!
Unrelated topic... Has anyone out there been in contact with Titan management lately? More to the point, has anyone gotten a reply from them?
I thought Trixie HAD a single port offering which the FDA shot down... they just missed the boat on the "then new" Human Factors Engineering guidelines, had insufficient redundancies, and insufficient IP portfolio to back it up if challenged, so they scrapped the project or sold it for peanuts. Maybe it is now the deli slicer that 2014 keeps harping about.
Anyway, as I understood it, Titan was slicing chicken in a bottle with a rudimentary system which needed much further development; meanwhile Trixie went to the FDA with their similar-state (rudimentary) offering (Surgibot) and got laughed at. Titan kept at it, securing patent after patent on ever-improving technology while nailing down all the requirements for a world-class medical instrument. The fact that Trixie didn't pursue their single-port device implies to me that maybe they knew they couldn't secure the patents needed because the competition (Titan and ISRG) had already locked everything down legally. This also raises the question as to who else can get into the single port space, given the IP that is already spoken for.
Now... can anyone point to Medtronics' vast IP holdings for single port? Or does it not exist? Just curious... I may have to raise my odds to 25% chance for that partnership!
Message in reply to:
Is TRXC still around? I remember when that was trading at $14/share, had a $1B market cap - man, people really got screwed on that but hey they put out a lot of PR's and really pumped up that company every chance they got. They always got money (then lost it)......just can't make up for a poor product. If they had a novel, next generation surgical robotic platform would have been very helpful. AND if they had SINGLE PORT on top of that, well they would have went from $14 to $40 a share and had over a $3B MC by now.
We hold Titan b/c they are moving forward and have milestones on the near horizon that will increase value exponentially. TRXC has none, it is already an FDA approved product in the market place and it has fallen to where it currently sits.......no holding onto that stock hoping it rebounds, how can it.
Ahh, Levity! That's the Ole HC I liked!
Actually, I don't know WHY shorts would be increasing their bets with regard to 9/24. I don't know what will happen then. If Medtronic announces a collaboration with Titan, those shorts would be screwed really hard. If Medtronic announces their own single port system, it further validates the marketplace for Titan, and also places a much higher value on their patent portfolio if more single port competition becomes public (for the record, I give it about a 20% chance at most that Medtronic and Titan sleep together).
Maybe shorts are increasing their positions as we speak, but I don't know why. If you know WHY, please share!
And... Are you a Marine? You certainly have my respect for that if you are!
Message in reply to:
Hey, 3rd grade was the best 3 years of my life ! Semper Fi
Hard to argue WHY shorts are increasing their bets as it gets closer to 9/24, though...will ya give me that much mango? oorah
Sorry Mharb... history has it that raises are preceded by increases, then a sudden drop the day before the raise is announced. Something leaky in this organization, methinks...
Message in reply to:
Sure. A run up before a raise. People just want to invest money to lose it. That makes perfect sense.
Can you explain your logic to this statement? Have you seen Titan running press releases to pump the pps?
To indicate an increase or decrease, you need a reference point.
9/11 to 9/12 went DOWN from 27.4% to 24.2%
9/12 to 9/13 went UP from 24.2% to 32.1%
9/13 to 9/16 went UP from 32.1% to 41.6%
9/16 to 9/17 is TBD.
You have only TWO consecutive UP days, today would make the third if it went up above 41.6%.
Oy Vey is right! You can't count to three but you want me to trust your statistical analysis prowess? Now I can't even rely on your reports of superior golf skill!
Message in reply to:
I just did show you 3 days in a row...look at 12th, 13th and 16th of SEPTEMBER 2019. Oy Freakin Vey
TMDI has been a well established playground for shorts for a long time. We are probably always twice as high as a normal stock for shorts. Show me three days in a row and I'll grant you a trend even if the statistics still don't back it up.
And I will blindly bet that today the short percentage goes down, disproving your trend theory.
Message in reply to:
Now, I blindly bet that yesterday would show an increase in short volume and it clearly did and you still have the ballz to be contentious ? Oy Vey - May God Bless You. Note - if the pros were nervous, it would be going down as it gets closer to 9/24. Short ratios of 20% are considered high... yesterday was 41.6% !
Statistically speaking, there is no actual increase. The data is too spotty to call it any sort of trend. You can pick two data points and call it a trend. Maybe you are older than me, but from that "data" we cannot extrapolate that everybody in your family is older than everyone in my family.
Maybe Aspire is actually betting that those same shares can get them $10M in profits in 6 months.
So 93k shares shorted out of 224k total volume yesterday. Just over 40% short means just over 60% not short. Like I said yesterday, nobody buys a stock thinking it will do nothing, so that other nearly 60% must think it is going up.
Your point that people think it's going down needs to be validated with better data than 50% more people think it's going up than down.
I'm a firm believer that data is good for anyone wise enough to look at both sides of it (I once owned a book entitled "How To Lie With Statistics" and I understand how to recognize many faulty analyses). What I will take from the data provided is that yes, over a 5 day span, the general "trend" for short shares is positive (meaning it is increasing, not meaning that it is good!). On the other hand, it bounces a bit too much for anyone to really consider it a "trend" from a pure statistical standpoint (if plotted on a graph, the points will stray too far from the mean). That means to me that it bears monitoring and for that, I appreciate your data input, despite my disagreement with your analysis of said data. Of the last 12 trading days, we see 6 drops in short % and 5 increases, so it fell more often than it rose.
Also, the latest "trend" is really only the past 2 trading days; the two sessions prior to those were both decreases. I graphed it in Excel; the spike on Sept 6 was nearly 2sd from the mean trendline, and a couple points are also close to 2sd from the sample mean. For such a small sample (only 12 data points) there simply is no statistically viable "trend" to be had from this data.
I'll post the actual numbers here with percentage for everyone to draw their own conclusions (percentages expressed as decimal fractions):
Date -- Volume -- Short -- % Short
9/16/2019 -- 224,204 --93,324 --0.416245919
9/13/2019 --194,813 --62,666 --0.321672578
9/12/2019 --224,062 --54,366 --0.242638198
9/11/2019 --237,841 --65,241 --0.274305103
9/10/2019 --158,509 --48,991 --0.309073933
9/9/2019 --222,473 --42,104 --0.189254426
9/6/2019 --101,856 --38,320 --0.376217405
9/5/2019 --197,328 --45,494 --0.23055015
9/4/2019 --58,165 --5,310 --0.091292014
9/3/2019 --243,992 --43,071 --0.17652628
8/30/2019 --264,000 --48,960 --0.185454545
8/29/2019 --86,396 --20,309 --0.235068753
Everyone is invited to copy/paste into their own spreadsheet or Minitab or whatever statistical analysis tool you prefer to use. Everyone should draw their own conclusions; I am willing to share mine here.
Ole HC, I don't mind you sticking around here for now... we won't always agree, and that is fine. I just hope you find some viable, rational content in my posts, as I do from some of yours. At least you keep the hostility level fairly low, even at your most smug moments! But we all go there once in a while.
Message in reply to:
Well, looks like the short interest only went UP yesterday. So, sorry for all of you that had your hopes up for me to NEVER post here again. It was a fairly heavy volume day for shorts vs. the last 5 folks.
https://shortvolume.com/
* Type in ticker and type in 5 days and see for yourself folks
93,324 was the short volume of TMDI from 9/16 folks (yesterday)
https://marketwirenews.com/stock/tmdi/short/ (review chart)
So what HC - what is your point ? Simply that people (and I would say non-retail) are taking the position that this goes DOWN instead of up soon. GLTA (be careful)
Do you take your cake out of the over after just 5 minutes? It's not done yet. Same applies here. One step at a time. I want to have my cake and eat it too, but I want it fully baked and fully presentable. You apparently prefer batter.
Message in reply to:
lmao....point is they haven't even filed it yet and won't until the re engineering is done....then approval...it's months away and in the meantime they burn what little cash they have....aside from that I had no point lmao
My point really is that the day IDE approval comes in, we should shoot up like a rocket. It is the ultimate validation of the technology and of Titan's system capabilities.
Message in reply to:
Good clarification mustang. Yes very important distinction and after all these years of talk, to think IDE is right around the corner is very material and very exciting. You'd have to be a stick in the mud to think otherwise.
IDE approval is done by the FDA so you are technically correct in that statement of "IDE approval is FDA approval." But it isn't 510k approval which says its okay to market the device.
Realize also that the IDE approval requires the applicant to meet 90%+ of the criteria for final 510k approval to market the device (safety. efficacy, etc.). The only real difference is the 510k approval also requires reports from the IRB to be reviewed by the FDA. With Colombia's likely involvement and possibly lead role in the IRB investigation and generation of those reports (with Dr. Advincula possibly at the helm), how bad could that last 10% be?
The IDE application is a milestone event. The IDE APPROVAL is possibly the most CRITICAL milestone event of this product's timeline.
Message in reply to:
RockoTaco
Monday, 09/16/19 05:29:40 PM
Re: Honeycomb777 post# 96079
Post # 96082 of 96096
IDE approval is FDA approval
https://www.fda.gov/medical-devices/device-advice-investigational-device-exemption-ide/ide-approval-process
Studies of devices that pose a significant risk require both FDA and an Institutional Review Board (IRB) approval prior to initiation of a clinical study. FDA approval is obtained by submitting an IDE application to FDA (§812.20)
Maybe it is option 4, which you failed to mention: None of the other options. Who says they are actively trading any Titan shares one way or the other? Only you... I believe the greatest likelihood is that they aren't moving shares either way, but you don't even consider it an option based on your prior post.
Why do you think they have to do something right now? It would be contrary to their stated mission.
Message in reply to:
Again we have NO IDEA what Aspire is doing here behind the scenes... are they:
1) Selling only (taking some profits)
2) Buying and Selling
3) Buying only (10% requires TSX approval = 3.11M common shares)
*** If it's 2 or 3, their cost basis is only rising folks.
Well, nobody buys a stock betting it does nothing. So if 33% of buyers think it's going down, that means 67% of buyers think it's going up. That's a 2 to 1 vote of confidence by Mr. Market. They must know the lay of the land. Wow.
Message in reply to:
I will be interested to see the Short Volume Ratio numbers for today's trading on Fintel. Last 4 trading sessions averaged ~33%. It's hard to argue the fact that there are still folks betting this goes down from here - and they must know the lay of the land.
One would think with 9/24 approaching that the ratio would be 15 or under ? Wow
I wonder if IDE approval will be enough to jump start this thing...
They've been working with the FDA for at least a couple years now so both sides understand the expectations. It is not inconceivable that the IDE comes back approved very quickly instead of the max allowable 30 days, given the history of interaction between the two organizations (Titan and FDA).
IDE approval should mean the FDA is at least convinced of some substantial level of safety and presumably also efficacy before granting the IDE.
Also, coincidentally (or not!), Columbia University is a viable IRB organization for single site or multi site studies (we have up to four sites to utilize) and Dr. Advincula hangs out at Colombia and hopefully will be involved in our IRB process.
We are so freakin' close...
I though it was King, so I stretched it to try to fit a "Royally Screwed" theme...
Message in reply to:
Haha brilliant! It's funny "rei" is actually latin for a "thing, matter or affair". One of the few things I remember from 3 years of high school latin.
It's as fair as any retail vs. wholesale transaction. Everyone ahead of retail in the marketing chain gets to pick their profit margin, and the retail customer foots the bill for everything - manufacturing overhead, materials, packaging, shipping, warehousing, stocking the shelf...
In fact, "retail" is from the Latin root "Rei" meaning Royally, and "Tail" meaning screwed in the Tail End! I think they mean the Tail End of the series of transactions which bring a product to market, not screwed in the...
But anyway, mu point is that non-retail anything usually makes out better than retail anything.
Message in reply to:
So THEY get a built in profit of over 2 milly and when retail investors risk their capital, they get lied to and lose 80% or more. Seems fair - thx !
Moose, you gotta pick up in the signals, dude! That Tootle guy was trying to help. They aren't analysts, they are analyists and analysists and when they get promoted, they become analysisists and analalysists! You need to pay more attention when folks like that are trying to help!
Geez, man, you just look silly calling them "analysts" over and over!
tootalljones Thursday, 09/12/19 03:32:37 PM
Re: elMoose post# 95882
Post # 95885 of 95888
elmoose, you would be hard pressed in any of the several hundred micro caps in the biotech and med tech area to find a single analysist for a single one of these 250+ companies that has a negative rating.
Think about that. Even the reputable analyists are semi fraudulent. When markets crater you will find 80% of analyists have buy targets and projected targets often way above the current price.
Analysists serve as basically hand in glove company mouthpieces, but their employers make their money investing in these companies very early, maybe grabbing warrants, and then distributing their shares to the public. They have other methods as well, but obviously, they are not making these price targets to kindly and benevolently help retail buyers.
The buyers are just refuse.
I challenge you to find me a single bio or med tech where an analyist has a price target lower than today's closing price. It is a fraud industry.
As long as it isn't "Everybody Needs Open Surgery"
Wish it was "Economically Nice for Our Stockholders"
Message in reply to:
Trademark ENOS - why the rebrand and what does it mean.
Only Titan knows what it stands for.
Einstein Navigational Operating System
EthicoN Operating System
You sound disappointed that pre-market is up 9%. I will never understand. Oy Vey.
Actually, most of us do understand, and we can't wait for your gravy train to leave the station for good.
Message in reply to:
So someone buys 1,975 pre open and if they would have waited could have likely bought 2,135 or More for the same outlay. I will never understand. Oy Vey
Moose, these are just Analysts ratings, not a computer algorithm which can't see or understand innovation. And we all know the Wall Street Journal is just a fly-by-night publication that gets no respect in the business world. I'd rather listen to a blind computer program because after all, who knows the robotic surgery market better than a computer program which has nothing to do with robotics or surgery?!
I guess I'll just sell all my shares because Barchart says I should.
Message in reply to:
Analyst Forecasts
3 analysts : Buy
Consensus Forecast : $5.33
https://quotes.wsj.com/TMDI/research-ratings
Rocko, first, nice to see you stick to your guns. I also will not be convinced to sell any time soon despite potential tax games; the risk to me is too great as well. And if long believed they should all sell now, the price would fall off a cliff, a dream scenario for folks betting against us... It's not my goal to help them crush our PPS.
More importantly... What is JnJ doing on the 24th? I only knew about Medtronics upcoming announcement.
Message in reply to:
Two takeaways from McNally Presentation:
1. Their system will have Augmented Reality built into it - very few software companies developing that for Robotic Surgery - I know one that is......
2. There are only 2 ways to do SINGLE PORT ROBOTIC SURGERY. Intuitive SP is one and TITAN IS THE OTHER. SINGLE PORT IS THE FUTURE - validated by Intuitives DaVinci SP and expert robotic surgeons desire for next generation. ANY BIGGUN WILL HAVE TO HAVE SINGLE PORT TO COMPETE.....
As a long, I am prevented by wash sales rules to sell my position to take a tax loss and then buy back in within 30 days - can't do it b/c I can't take advantage of the tax loss - not worth it to me for a hundred extra shares (which is unlikely it will even go down that much if at all). Risk to me is loss of potentially $100's of thousands maybe in the millions , IMO don't think it will go down so if I sell now and the PPS goes up I then have LESS shares - not a good or smart move for me to do. I think I will hold onto my shares right now and see what Medtronic has on Sept 24th as well as JNJ on Sept 24th.
Backfermore, let me throw out a supposition for you...
What if you are right, Mr. Zaring bleeds JnJ and his deeper loyalty is to them. He jumped ship to Mazor to get JnJ's foot in the door so they could work on a JnJ/Mazor deal. Deal falls through when Medtronic outbids JnJ. Now JnJ still needs to get into the robotics market, still feeling stung by losing out on the Mazor deal. Medtronic still wants to beef up their robotics portfolio and thinks Mr. Zaring is now their inside guy with Titan - but he is really pulling for JnJ! JnJ could refuse to lose another bidding war to Medtronic. Losers: Medtronic. Winners: JnJ and Titan longs!
It would certainly be an entertaining scenario for us!
Message in reply to:
Taco you say JNJ is hiring in Chapel Hill for same positions that are going to be needed with Titan. Also I have heard you say that Zaring came from JNJ. Would he jump ship If he knew that JNJ was one of Titans Manufacturing partners? That would eventually mean a shite bag of money with all the options he received??
Could he still bleed JNJ as his roots are with them?